Position paper of the Working Group of three Polish National Consultants in internal medicine, gastroenterology, and cardiology on prevention of gastrointestinal complications during antiplatelet treatment

Polskie Archiwum Medycyny Wewnetrznej

Volumn 119, Issue 6, 2009, Pages 347-348

  Imiela, Jacek ^a   Opolski, Grzegorz ^b   Rydzewska, Grazyna ^c   Baczewska Mazurkiewicz, Dorota ^c   Małecki, Robert ^a   Filipiak, Krzysztof J ^b,d  

^a Laboratory of Nuclear Medicine   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c Central Hospital   (Poland)

^d WARSZAWSKI UNIWERSYTET MEDYCZNY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PROTON PUMP INHIBITOR;

CARDIOLOGY; CARDIOVASCULAR DISEASE; DRUG EFFICACY; EDITORIAL; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; GROUPS BY AGE; HELICOBACTER PYLORI; HUMAN; INTERNAL MEDICINE; LOW DRUG DOSE; MEDICAL SOCIETY; PEPTIC ULCER; POST HOC ANALYSIS;

EID: 67650496198     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.703     Document Type: Editorial

References (7)

1. Bhatt DL, Scheiman J, Abraham NS et al. ACCF/ACG/AHA 2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008; 52: 1502-1517.
2. Gilard M, Arnaud B, Cornily JC et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008; 51: 256-260.
3. Small DS, Farid NA, Payne CD et al. Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel. J Clin Pharmacol. 2008; 48: 475-484.
4. Ho PM, Maddox TM, Wang L et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301: 937-944.
5. Siller-Matula JM, Spiel AO, Lang IM et al. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009; 157: 148.e1-5
6. Juurlink DN, Gomes T, Ko DT et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009; 31: 180-187.
7. Sibbing D, Morath T, Stegherr J et al. Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel. Thromb Haemost. 2009; 101: 714-719.